Glen Eagle Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2029317
KINGSTON, NJ
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$71,707
-$16,373 QoQ
Shares Held
115
+0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,104
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $278,065 across 14 Biotechnology names. REGN ranks #2 (25.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
178 | $88,417 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
115 | $71,707 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
200 | $37,456 | |
| 4 | SLS |
SELLAS Life Sciences Group, Inc.
|
2,176 | $32,117 | |
| 5 | PRME |
Prime Medicine, Inc.
|
5,000 | $18,450 | |
| 6 | BNTX |
BioNTech SE
|
100 | $9,305 | |
| 7 | GMAB |
Genmab A/S
|
200 | $5,494 | |
| 8 | EXEL |
Exelixis, Inc.
|
89 | $4,842 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,707 | 115 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $88,080 | 114 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $59,433 | 77 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $65,785 | 117 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $66,150 | 126 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $86,255 | 136 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $96,876 | 136 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $142,968 | 136 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $142,940 | 136 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $121,273 | 126 | Shares | Sole | 2024-07-03 | |
| 2023-12-31 | $112,421 | 128 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $105,338 | 128 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $91,973 | 128 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $105,173 | 128 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $93,072 | 129 | Shares | Sole | 2024-08-13 | |
| 2022-09-30 | $88,175 | 128 | Shares | Sole | 2024-08-13 | |
| 2022-06-30 | $80,393 | 136 | Shares | Sole | 2024-08-13 | |
| 2022-03-31 | $94,985 | 136 | Shares | Sole | 2024-08-13 | |
| 2021-12-31 | $85,886 | 136 | Shares | Sole | 2024-08-13 | |
| 2021-09-30 | $82,304 | 136 | Shares | Sole | 2024-08-13 | |
| 2021-06-30 | $78,754 | 141 | Shares | Sole | 2024-08-13 | |
| 2021-03-31 | $95,101 | 201 | Shares | Sole | 2024-08-13 | |
| 2020-12-31 | $121,260 | 251 | Shares | Sole | 2024-08-13 | |
| 2020-09-30 | $145,542 | 260 | Shares | Sole | 2024-08-13 | |
| 2020-06-30 | $162,149 | 260 | Shares | Sole | 2024-08-13 | |
| 2020-03-31 | $74,220 | 152 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||